Ferozsons Labs and Procheck Sign Agreement to Protect against Counterfeiting & Improve Patient Health Outcomes
11th November 2015
Ferozsons Laboratories Limited, a leading manufacturer of pharmaceuticals listed on the Karachi Stock Exchange, and ProCheck have announced today that Ferozsons Laboratories will be protecting up to 35 million units of medicine using ProCheck’s serialization/ track & trace solution. In doing so, Ferozsons becomes the first pharmaceutical company in Pakistan to implement serialization.
Several of the company’s leading brands will be uniquely coded. Once implemented, patients will be able to find unique codes on every strip of these brands when they purchase them. To verify the authenticity of their product, they would simply need to SMS the code to 9900. More than 50,000 patients will avail the service leading to improved health outcomes. Osman Khalid Waheed, President of Ferozsons Laboratories Limited, said “Ferozsons is committed to using the latest technology to protect patient safety and help patients achieve their desired clinical outcomes. ProCheck’s treatment adherence solution can be a game changer by driving positive health outcomes through improved compliance in addition to protecting patients from counterfeit products. We are privileged to be the pioneer in using serialization and treatment adherence in Pakistan.”
The solution will be integrated at Ferozsons’ production facility. Ferozsons Laboratories chose ProCheck’s technology because of its ability to seamlessly integrate at the production site. ProCheck’s CEO, Saim Siddiqui said“We are excited to be working with Pakistan’s fastest growing public pharmaceutical company. Ferozsons is aligned with our vision of manufacturers thinking beyond the pill and encouraging positive health outcomes through digital means. Ferozsons’ pioneering initiative, one where brand protection is a means to improve compliance, is the future of pharma in the developing world.”
About Ferozsons Laboratories:
Ferozsons Laboratories Limited is a publicly traded pharmaceutical company ranked amongst the top pharmaceutical manufacturers in Pakistan, and has a presence in 14 countries abroad. They manufacture a range of branded generics, and are distribution partners for some of the world’s best healthcare companies, including Gilead Sciences Inc., USA and Boston Scientific Inc., USA. Please visit www.ferozsons-labs.com for more information.
ProCheck’s mission is to use technology to improve the lives’ of patients and consumers in Pakistan. ProCheck provides a serialization/Track & Trace solution for the verification of consumer products, treatment adherence programs for improving patient health outcomes, and market Intelligence tools to increase manufacturers’ line of sight in to sales and distribution. Please visit www.procheck.pk for more information on the company.